The readout for the phase 3 trial of Ziltivekimab is expected in June 2026 if it works, and if its safe, it could establish IL6 inhibition as a new standard of care for cardiovascular risk reduction in chronic kidney disease
BPC-157 works best when the rest of the recovery environment is strong
Whenever this type of diet is followed, it may be useful to opt for vitamin B12-enriched products, such as rice- and soy-base drinks
Clin Nutr 21 : 505514 Ragusa RJ, Chow CK, Porter JD 1997 Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy
Zhang P, Zhang H, Wu G, et al (2021) Dose-Dependent Application of Straw-Derived Fulvic Acid on Yield and Quality of Tomato Plants Grown in a Greenhouse